Therapy News and Research

RSS

"Kangaroo care" delivers benefits beyond bonding and breastfeeding for tiniest newborns

New research in the Journal of Newborns & Infant Nursing Reviews concludes that so-called "kangaroo care" (KC), the skin-to-skin and chest-to-chest touching between baby and mother, offers developmentally appropriate therapy for hospitalized preterm infants.

11 Jul 2013

UNMC conducts clinical trial on Leukine to test unique immune therapy in people with Parkinson's

The Nebraska Neuroscience Alliance at the University of Nebraska Medical Center, is embarking on a translational clinical trial using Leukine, a drug used to boost the immune system in cancer patients, to test a unique immune therapy in people with Parkinson's disease.

11 Jul 2013

Researchers develop new tool for comprehensive mapping of cell-cell communication

Researchers at Memorial Sloan-Kettering Cancer Center, together with collaborators in Germany, have developed a new method for identifying the cell of origin of intracellular and secreted proteins within multicellular environments.

11 Jul 2013

Advanced genetics technologies may help predict patient outcomes in people with ALL

New evidence suggests that using advanced genetics technologies to monitor for remaining cancer cells after treatment may soon become an effective tool to inform treatment decisions and ultimately predict patient outcomes for patients with a particularly aggressive form of acute lymphocytic leukemia (ALL).

10 Jul 2013

Pharmacyclics submits ibrutinib NDA to FDA for two B-cell malignancies

Pharmacyclics, Inc. today announced that it has submitted a New Drug Application to the U.S. Food and Drug Administration for the investigational oral Bruton's tyrosine kinase inhibitor, ibrutinib, for two relapsed/refractory B-cell malignancy indications: mantle cell lymphoma and chronic lymphocytic leukemia/small lymphocytic lymphoma.

10 Jul 2013

Physicians discuss use of new guidelines on aromatase inhibitor to prevent breast cancer

The American Society of Clinical Oncology (ASCO) is now recommending that physicians discuss use of the aromatase inhibitor exemestane (Aromasin) to prevent breast cancer in at-risk postmenopausal women.

10 Jul 2013

Orlando Health and UF health partner to expand neurosurgery program

Orlando Health and the University of Florida department of neurosurgery have partnered to expand the neurosurgery program at Orlando Health with the opening of a specialized practice, UF Health Neurosurgery — Orlando Health.

10 Jul 2013

Dual antiplatelet therapy improves outcomes in patients undergoing coronary stenting

Emmanouil S. Brilakis, M.D., Ph.D., of the VA North Texas Health Care System and University of Texas Southwestern Medical Center at Dallas, and colleagues conducted a review of medical literature regarding optimal medical therapy after percutaneous coronary intervention (PCI; procedures such as balloon angioplasty or stent placement used to open narrowed coronary arteries).

10 Jul 2013

AOSSM presents awards and grants to encourage research in orthopaedic sports medicine

In order to recognize and encourage cutting-edge research in key areas of orthopaedic sports medicine, the American Orthopaedic Society for Sports Medicine (AOSSM) will present ten research awards and seven grants during its Annual Meeting, July 11-14 in Chicago, IL.

10 Jul 2013

Curetis starts prospective clinical trial for Unyvero P50 pneumonia application

Curetis AG today announced the start of an additional prospective, multicenter clinical trial of its marketed Unyvero™ P50 Pneumonia Application to demonstrate its clinical and health economic value.

10 Jul 2013

Study examines whether better sleep lowers risk of heart disease

The University of South Florida College of Nursing is conducting research to improve sleep in those caring for people with dementia and Alzheimer's disease, with the aim of determining if better sleep affects heart health.

10 Jul 2013

Innovative vaccine could offer hope to patients with advanced ovarian cancer

Loyola University Medical Center is conducting a clinical trial of an innovative vaccine that could offer hope to patients with advanced ovarian cancer.

10 Jul 2013

Study shows rates of brain loss caused by aging and AD are higher for women

The rates of regional brain loss and cognitive decline caused by aging and the early stages of Alzheimer's disease (AD) are higher for women and for people with a key genetic risk factor for AD, say researchers at the University of California, San Diego School of Medicine in a study published online July 4 in the American Journal of Neuroradiology.

10 Jul 2013

Diclegis delayed-release tablets for NVP treatment now eligible for Medicaid coverage

Duchesnay USA today announced that Diclegis (doxylamine succinate 10mg, pyridoxine hydrochloride 10mg) delayed-release tablets for the treatment of nausea and vomiting of pregnancy, more commonly known as morning sickness, is now available for coverage under the state and federal Medicaid program effective July 1st, 2013.

9 Jul 2013

Action Medical Research funds three new Research Training Fellowships

Action Medical Research, the UK-wide charity funding vital research to help sick and disabled babies and children, has today announced it is funding three new Research Training Fellowships worth more than £470,000.

9 Jul 2013

Stem cells in the aesthetic industry: an interview with Dr. Norma Kassardjian

Stem Cells are special “master” cells in your body. Stem cells are the building blocks that can replicate into other kinds of cells like blood cells, heart, muscle, blood vessels and cartilage.

9 Jul 2013

State highlights: Ore. nonprofit hospitals see increased revenue, but lower charity care; Calif. shift means lost autism treatment

A new state report shows the average Oregon hospital more than doubled its margin, or profit, between 2009 and 2011, even as its provision of charity care went down. The findings trace the hospital sector rebound from recessionary lows in 2008, and how expanded Medicaid enrollment in Oregon has helped boost hospitals' bottom line even as many continue to expand to some assessors' dismay (Budnick, 7/5).

9 Jul 2013

Cancer immunotherapies promise to be a new tool in fight against cancer

Drugs that direct a cancer patient's immune system to eradicate her or his disease, known as cancer immunotherapies, promise to be a new tool in the fight against cancer. Since the Koch Institute's inception, exploring the close relationship between the immune system and cancer has been one of the Institute's priority research areas.

9 Jul 2013

Physicians have new resource for managing disease in patients with early-stage breast cancer

Physicians have a new resource for managing disease in patients with early-stage breast cancer. Patients diagnosed with ductal carcinoma in situ -- cancer that has not left the breast ducts -- now have the benefit of a multi-gene analysis that considers gene patterns to individualize therapy and determine the chance for recurrence, potentially sparing the patient additional therapy.

9 Jul 2013

Macrophages play essential role in production of progesterone hormone

New research from the University of Adelaide shows for the first time that immune cells known as macrophages are critical to fertility by creating a healthy hormone environment in the uterus.

9 Jul 2013

Therapy News and Research

"Kangaroo care" delivers benefits beyond bonding and breastfeeding for tiniest newborns

UNMC conducts clinical trial on Leukine to test unique immune therapy in people with Parkinson's

Researchers develop new tool for comprehensive mapping of cell-cell communication

Advanced genetics technologies may help predict patient outcomes in people with ALL

Pharmacyclics submits ibrutinib NDA to FDA for two B-cell malignancies

Physicians discuss use of new guidelines on aromatase inhibitor to prevent breast cancer

Orlando Health and UF health partner to expand neurosurgery program

Dual antiplatelet therapy improves outcomes in patients undergoing coronary stenting

AOSSM presents awards and grants to encourage research in orthopaedic sports medicine

Curetis starts prospective clinical trial for Unyvero P50 pneumonia application

Study examines whether better sleep lowers risk of heart disease

Innovative vaccine could offer hope to patients with advanced ovarian cancer

Study shows rates of brain loss caused by aging and AD are higher for women

Diclegis delayed-release tablets for NVP treatment now eligible for Medicaid coverage

Action Medical Research funds three new Research Training Fellowships

Stem cells in the aesthetic industry: an interview with Dr. Norma Kassardjian

State highlights: Ore. nonprofit hospitals see increased revenue, but lower charity care; Calif. shift means lost autism treatment

Cancer immunotherapies promise to be a new tool in fight against cancer

Physicians have new resource for managing disease in patients with early-stage breast cancer

Macrophages play essential role in production of progesterone hormone

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News